ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОЙ ТЕРАПИИ ПРИ I И II ПРОФИЛАКТИКЕ ССЗ.htm

182.Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. Feb 12 2009;360(7):668-678.

183.Adherence to long-term therapies : evidence for action. Geneva: WHO; 2003.

184.Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin. Sep 2005;21(9):14531460.

185.Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens. Jul 1995;9 Suppl 2:S15-18.

186.Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. Aug 4 2005;353(5):487-497.

187.Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. Oct 1998;4(10):1421-1430.

188.Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. Jan 1986;24(1):67-74.

189.Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia. Jul 2008;49(7):1115-1122.

190.Незнанов Н.Г., Вид В.Д. Проблема комплаенса в клинической психиатрии. Психиатрия и психофармакотерапия. 2004;6(4):159-162.

191.Izzo JL, Black HR, Goodfriend TL. Hypertension primer : the essentials of high blood pressure. 3rd ed. ed. Philadelphia: Lippincott Williams & Wilkins; 2003:390-392.

192.Joyce CR, Caple G, Mason M, Reynolds E, Mathews JA. Quantitative study of doctor-patient communication. Q J Med. Apr 1969;38(150):183-194.

193.Makaryus AN, Friedman EA. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. Aug 2005;80(8):991-994.

194.Neutel JM, Smith DH. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens (Greenwich). Mar-Apr 2003;5(2):127-132.

195.Плавинский С.Л., . Мероприятия по усилению приверженности терапии. 2007:48.

196.Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. Aug 8-22 2005;165(15):1749-1755.

197.Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. Jul 1997;10(7 Pt 1):697-704.

198.Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. Aug 1996;9(8):719-725.

199.Wrigley S, Jackson H, Judd F, Komiti A. Role of stigma and attitudes toward help-seeking from a general practitioner for mental health problems in a rural town. Aust N Z J Psychiatry. Jun 2005;39(6):514-521.

200.Воробьев П.А., ed Клинико-экономический анализ. Москва: «Ньюдиамед»; 2008.

201.ОСТ «Клинико-экономические исследования. Общие положения. 91500.14.0001-2002».